EUVIMEDEUVIMED entdecken
Crossref

Retracted Evidence and Emerging Insights: A Meta-Analytic Reassessment of the Probiotics Supplementation as an Adjunctive Therapy in Relapsing-Remitting Multiple Sclerosis

Reza Mosaddeghi-Heris, Niloufar Pourakbar, Niloofar Taheri, Mahnaz Talebi, Sarvin Sanaie, Amirreza Naseri

Pharmaceutical Sciences · 31.07.2026 · 32 (3) · 479-481

DOI: 10.34172/ps.43403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Sciences, online erschienen am 31.07.2026. Verfasst von Reza Mosaddeghi-Heris und 5 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mosaddeghi-Heris, R., Pourakbar, N., Taheri, N., Talebi, M., Sanaie, S., & Naseri, A. (2026). Retracted Evidence and Emerging Insights: A Meta-Analytic Reassessment of the Probiotics Supplementation as an Adjunctive Therapy in Relapsing-Remitting Multiple Sclerosis. Pharmaceutical Sciences, 32(3), 479-481. https://doi.org/10.34172/ps.43403

Vancouver

Mosaddeghi-Heris R, Pourakbar N, Taheri N, Talebi M, Sanaie S, Naseri A. Retracted Evidence and Emerging Insights: A Meta-Analytic Reassessment of the Probiotics Supplementation as an Adjunctive Therapy in Relapsing-Remitting Multiple Sclerosis. Pharmaceutical Sciences. 2026;32(3):479-481. doi:10.34172/ps.43403

BibTeX
@article{MosaddeghiHeris2026,
  author = {Mosaddeghi-Heris, Reza and Pourakbar, Niloufar and Taheri, Niloofar and Talebi, Mahnaz and Sanaie, Sarvin and Naseri, Amirreza},
  title = {Retracted Evidence and Emerging Insights: A Meta-Analytic Reassessment of the Probiotics Supplementation as an Adjunctive Therapy in Relapsing-Remitting Multiple Sclerosis},
  journal = {Pharmaceutical Sciences},
  year = {2026},
  volume = {32},
  number = {3},
  pages = {479--481},
  doi = {10.34172/ps.43403}
}
Kostenlos starten →